AptarGroup (ATR) Q1 2025 Earnings Call May 02, 2025 09:00 AM ET Company Participants Mary Skafidas - Senior VP of IR & Corporate CommunicationsStephan Tanda - President, CEO & Executive DirectorVanessa Kanu - Executive VP & CFOGeorge Staphos - Managing Director Conference Call Participants Ghansham Panjabi - Senior Research AnalystMatthew Roberts - Equity Research AnalystDaniel Rizzo - AnalystMatt Larew - Research Analyst - HealthcareGabe Hajde - Analyst Operator Ladies and gentlemen, thank you for standing ...

Financial Data and Key Metrics Changes - Fundraising in Q1 2025 reached a record $3.2 billion, contributing to a target of $6 billion for the year [6][24] - Fee-related earnings (FRE) were $42.6 million or $0.27 per share, reflecting a 2116% year-over-year growth [6][8] - Assets under management (AUM) grew to $46 billion, a 43% increase year-over-year and over 9% sequentially [10][26] - Distributable earnings were $37 million or $0.23 per share, up 12% year-over-year [8][32] Business Line Data and Key Metrics Changes - Fee-earning AUM increased to $35 billion, a 46% year-over-year growth and 6% sequentially [10][28] - Organic net inflows into fee-earning AUM were over $700 million, representing an annualized organic growth rate of over 8.6% [7][26] - Management fee revenue for Q1 was $77.3 million, up 28% year-over-year, but down 17% sequentially due to seasonal factors [28][29] Market Data and Key Metrics Changes - Approximately 20% of fee-earning AUM were in permanent capital vehicles, which is a key long-term objective [13][22] - Strong demand from Asian sovereign wealth fund investors led to $1 billion in commitments during the quarter [14][15] - Local investors accounted for approximately 17% of fundraising in Q1 2025, indicating a growing interest in alternative investments [22] Company Strategy and Development Direction - The company aims to diversify its investment strategies and product offerings, enhancing resilience against global uncertainties [23][24] - The focus is on organic growth through customized investment accounts and special managed accounts, moving away from a product-centric model [6][12] - The company is positioned to benefit from geopolitical shifts, with a low exposure to U.S. tariffs and a focus on local consumption markets in Latin America [17][39] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving the $6 billion fundraising target despite global uncertainties [24][31] - The company believes Latin America is becoming a more attractive destination for capital, benefiting from low geopolitical risks and strong local consumption [18][39] - Management anticipates that the ongoing trade conflicts may lead to increased foreign direct investment (FDI) in the region [42] Other Important Information - The company has a net debt of approximately $143 million, with a net debt to FRE ratio well below one time [32] - The effective tax rate for the quarter was 9.2%, with expectations to trend towards 10% by 2027 [32] - A quarterly dividend of $0.15 per share was approved for 2025, with intentions to repurchase shares throughout the year [33] Q&A Session Summary Question: How are portfolios positioned regarding higher tariffs in the U.S.? - Management indicated that most investments are Latin America-oriented, with minimal exposure to Mexico, and sectors are resilient and locally driven [37][39] Question: Could Chinese institutions divert allocations from U.S. to LatAm? - Management confirmed that there is increased interest from Asian investors, with significant commitments already made [43][45] Question: Is there potential upside to the $6 billion fundraising target? - Management maintained the $6 billion target but acknowledged the strong start with $3.2 billion raised in Q1 [52][54] Question: Update on integration of M&A completed last year? - Management reported that 2025 is focused on integration, with no major issues encountered and synergies expected to improve margins [70][74] Question: Overview of the $3.5 billion pending fee AUM? - Management stated that most pending AUM will be allocated to infrastructure and GPMS verticals, with an average management fee of 96 basis points expected [78][80]

Pebblebrook Hotel Trust (PEB) Q1 2025 Earnings Call May 02, 2025 09:00 AM ET Company Participants Raymond Martz - Co-President, CFO, Treasurer & SecretaryJon Bortz - Chairman & CEOJay Kornreich - VP - Equity ResearchSmedes Rose - DirectorFloris van Dijkum - Managing DirectorThomas Fisher - Co-President & Chief Investment OfficerDuane Pfennigwerth - Senior Managing DirectorJamie Feldman - Managing DirectorAri Klein - Director - Equity Research Conference Call Participants Shaun Kelley - Senior Research Analy ...

Plymouth Industrial REIT (PLYM) Q1 2025 Earnings Call May 02, 2025 09:00 AM ET Company Participants John Wilfong - Senior Vice PresidentJeffrey Witherell - Chairman & CEOJames Connolly - Executive Vice President of Asset ManagementAnthony Saladino - President and CFORich Anderson - Managing DirectorEric Borden - Vice President Conference Call Participants Todd Thomas - Managing Director & Equity Research AnalystNick Thillman - Senior Research AnalystMichael Mueller - Analyst Operator Please note today's eve ...

Select Medical (SEM) Q1 2025 Earnings Call May 02, 2025 09:00 AM ET Company Participants Robert Ortenzio - Co-Founder & Executive ChairmanMartin Jackson - Senior Executive Vice President of Strategic Finance & OperationsBen Hendrix - Vice PresidentBill Sutherland - Director of Research Conference Call Participants Justin Bowers - AnalystAnn Hynes - Senior Healthcare Services Equity Analyst & Managing Director Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's ...

AptarGroup (ATR) Q1 2025 Earnings Call May 02, 2025 09:00 AM ET Company Participants Mary Skafidas - Senior VP of IR & Corporate CommunicationsStephan Tanda - President, CEO & Executive DirectorVanessa Kanu - Executive VP & CFOGeorge Staphos - Managing Director Conference Call Participants Ghansham Panjabi - Senior Research AnalystMatthew Roberts - Equity Research AnalystDaniel Rizzo - AnalystMatt Larew - Research Analyst - HealthcareGabe Hajde - Analyst Operator Ladies and gentlemen, thank you for standing ...

Olin (OLN) Q1 2025 Earnings Call May 02, 2025 09:00 AM ET Company Participants Steve Keenan - Director of Investor RelationsKenneth Lane - President, CEO & DirectorTodd Slater - SVP & CFODavid Begleiter - DirectorJosh Spector - Executive DirectorKevin McCarthy - PartnerFrank Mitsch - PresidentVincent Andrews - Managing DirectorJohn Roberts - Managing DirectorMatthew Blair - Managing DirectorMichael Sison - Managing Director Conference Call Participants Patrick Cunningham - Vice President, Senior AnalystAlek ...

CTO Realty Growth (CTO) Q1 2025 Earnings Call May 02, 2025 09:00 AM ET Company Participants Jenna McKinney - Director of FinanceJohn Albright - President and CEOPhilip Mays - Senior VP, CFO & TreasurerRJ Milligan - Managing DirectorRob Stevenson - Managing Director - Head of Real Estate ResearchMatthew Erdner - DirectorGaurav Mehta - Managing DirectorCraig Kucera - MD - Equity Research Conference Call Participants John Massocca - Senior Research Analyst Operator Good day and thank you for standing by. Welco ...

Streamline Health Solutions (STRM) Q4 2025 Earnings Call May 02, 2025 09:00 AM ET Company Participants Jacob Goldberger - VP - FinanceBen Stilwill - President & CEOBryant Reeves - Chief Financial OfficerNeil Cataldi - Principal Operator As a reminder, this conference is being recorded. It is now my pleasure to introduce Jacob Goldberger, Vice President of Finance. Thank you. You may begin. Jacob Goldberger Thank you for joining us for the corporate update and financial results review of Streamline Health So ...

Select Medical (SEM) Q1 2025 Earnings Call May 02, 2025 09:00 AM ET Company Participants Robert Ortenzio - Co-Founder & Executive ChairmanMartin Jackson - Senior Executive Vice President of Strategic Finance & OperationsBen Hendrix - Vice PresidentBill Sutherland - Director of Research Conference Call Participants Justin Bowers - AnalystAnn Hynes - Senior Healthcare Services Equity Analyst & Managing Director Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's ...